TORONTO, March 10, 2020 – TruTrace Technologies Inc. (CSE: TTT) (OTCQB: TTTSF) (“TruTrace” or the “Company”), today announced the appointment of Cesare Fazari to its Board of Directors, effective March 9, 2020.
Mr. Fazari is a founding partner of Northwood Developments and has been active in the company for over 30 years. He specializes in commercial retail rollout, having completed thousands of turnkey projects for major commercial franchises such as Shoppers Drug Mart, Marshalls, Trade Secrets and Public Mobile to name a few.
With his entrepreneurial vision, Mr. Fazari has been the seed Venture Capital investor in many successful public companies such as Hydropothacary Corp., Ianthus, Drone Delivery Services and others. Mr. Fazari also previously sat on the board of the public merchant bank, Fountain Asset Corporation and is currently on the advisory board of several public and private companies. Mr. Fazari is actively involved in charitable organizations including The Breakfast Club of Canada, The Canadian Cancer Society and the Good Shepard Food Bank.
TruTrace also announced that Swapan Kakumanu has resigned from his position as a Director effective March 9, 2020, and continues to serve as Chief Financial Officer and Secretary of the Company. The Company wishes to thank Mr. Kakumanu for his service and contributions to the Board.
About TruTrace Technologies:
TruTrace Technologies has developed an integrated blockchain platform to register and track intellectual property in the cannabis industry. TruTrace’s technology allows cannabis growers and breeders to identify and secure rights to their intellectual property. It also streamlines the administrative process and reduces the costs of genetic and mandatory quality-control testing for legal cannabis. TruTrace’s technology is proprietary, immutable and cryptographically secure, thereby establishing an accurate and permanent account for cannabis strains from ownership to market.
For Information:
Robert Galarza,
Chief Executive Officer and Director,
844-656-3629.
Investor Inquiries:
Swapan Kakumanu,
Chief Financial Officer,
844-656-3629, swapan@trutrace.co